W16P-0576

N/A

Report date: 2025/01/26 15:11:10
NME

Base Information

Drug NameW16P-0576
Drug Alias NameW16P-0576
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcinetobacter Baumannii InfectionsPsoriasisEczema +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphanosos SAS
China Registration ClassN/A

Develop Information

Active CompaniesAlphanosos SAS
Inactive CompaniesN/A
Active IndicationsAcinetobacter Baumannii InfectionsPsoriasisEczema +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A